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Enterococcus faecium strain 10/96A (VanD4) was the first vancomycin-resistant enterococcus (VRE) isolated
in Brazil. Subsequent Brazilian VRE strains have all had the VanA phenotype. Multilocus sequence typing
showed that strain 10/96A was isolated sporadically, has a unique sequence type (ST 281), and was not the
progenitor of the VRE strains isolated from hospital outbreaks in Brazil.
Vancomycin-resistant enterococci (VRE) have been isolated
since the late 1980s in Europe (17) and in the United States
(15). In Brazil, the first VRE strain was isolated in 1996, when
a vancomycin-resistant strain of Enterococcus faecium was iso-
lated from the blood of a 9-year-old girl with aplastic anemia
(7). The VanD-like phenotype of this isolate was later classi-
fied as VanD4 (6). Subsequent to this initial case, there have
been several reports of VRE strains in Brazil, including reports
of intra- and interhospital spread of strains (3, 5, 13, 18).
However, most of these subsequent strains have had the VanA
phenotype; no other VanD strains have been reported in Bra-
zil, although they have been identified, albeit rarely, elsewhere
(1, 2, 14).
Acquired VanD-type vancomycin resistance is due to the
constitutive production of peptidoglycan precursors ending in
D-alanine-D-lactate, except for E. faecium A902 (VanD2),
which is reported to have inducible resistance (9, 11). The
organization of the vanD operon, which is located on the chro-
mosome of the strains thus far examined, is similar to that of
vanA and vanB, except for the vanX and vanW genes (9). In
vitro transfer of vanD operons by conjugation to other entero-
cocci strains has not been demonstrated. VanD strains have
negligible D,D-dipeptidase (VanX) activity. This is essential in
other vancomycin-resistant phenotypes to eliminate the intra-
cellular pool of peptidoglycan precursors terminating in D-
alanyl-D-alanine (8). However, D,D-dipeptidase activity ap-
pears to be unnecessary in most VanD strains; their native Ddl
ligases—required to generate the D-alanyl-D-alanine precur-
sor pool—are inactive, owing to mutations in the chromosomal
ddl gene (9). Most VanD enterococci strains have mutations in
the VanSD sensor or VanRD regulator proteins, and their
vanD clusters are expressed constitutively (9), which eliminates
the need for vancomycin induction for synthesis of critical cell
wall precursors and circumvents vancomycin dependence.
The vanD gene clusters and ddl genes have been examined
in several VanD phenotype strains, and several mutations have
been described (5). However, it remains unclear how or when
the vanD gene cluster was acquired. We have used multilocus
sequence typing (MLST) to further analyze the original van-
comycin-resistant VanD4 isolate from Brazil, E. faecium strain
10/96A, and to compare it with VanA strains isolated in Brazil
(4) and elsewhere (http://efaecium.mlst.net/). The value of this
MLST approach is that the predicted founder and descent of
clusters of related isolates can be identified (10). Hence, we
sought to determine the relatedness of strain 10/96A to sub-
sequent VanA strains of E. faecium from Brazil and to deter-
mine whether it represents the progenitor of the strains re-
sponsible for outbreaks in Brazilian hospitals.
DNA was isolated from E. faecium strain 10/96A (VanD4)
by detergent cell lysis as described previously (16). For MLST,
internal fragments of seven housekeeping genes (adk, atpA,
ddl, gyd, gdh, purK, and pstS) were amplified with specific
primers, using reaction conditions as previously described (12).
PCR-amplified fragments were sequenced on both strands,
using the ABI PRISM Big Dye Cycle Sequencing Ready Re-
action kit (Perkin-Elmer) and an ABI 3100 sequencer (Perkin-
Elmer). The nucleotide sequences were compared with alleles
deposited in the E. faecium MLST database (http://efaecium
.mlst.net/). A sequence type (ST) was assigned, and a diagram
of the most-related STs was constructed, using tools available
at http://efaecium.mlst.net/. The sequences of E. faecium ddl
genes were also compared, and the relative position of the
strain 10/96A allele on the diagram was determined using
PhyloDraw version 0.8 (http://pearl.cs.pusan.ac.kr/phylodraw
/#test).
To our knowledge, E. faecium strain 10/96A is the first VanD
strain subjected to MLST and deposited in the database. The
ddl gene of strain 10/96A represented a novel allele, owing to
a unique G3A transversion (9), and has been designated
allele Ddl24. This allele differed from 25 other ddl alleles in the
database but clustered most closely with alleles 25, 3, 10, and
19 (Fig. 1). Based on analysis of all seven MLST loci, strain
10/96A has the novel allelic profile AtpA9, Ddl24, Gdh1,
PurK18, Gyd1, PstS1, and Adk3 (or 9, 24, 1, 18, 1, 1, 3) and
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represents a new ST, which has been designated ST 281. Only
two of 298 STs in the E. faecium MLST database were types
closely related to ST 281. These types were ST 99 (linked to
one strain from Poland) and ST 170 (linked to one strain
from Tanzania), both of which share five of seven alleles
with ST 281 and are double-locus variants of it. ST 99 and
ST 170 differ from ST 281 by having alleles Ddl5 and PstS21
and alleles Ddl3 and PurK5, respectively. An eBURST anal-
ysis of all STs in the database was constructed (Fig. 2); the
algorithms judged ST 99 to be evolutionarily more closely
related to ST 281 than ST 170.
E. faecium 10/96A (VanD4) was isolated in 1996; no other
VanD4-type strains have been isolated in Brazil. Consistent
with this, strain 10/96A represented a unique ST, ST 281. Most
subsequent Brazilian VRE strains have a VanA phenotype,
and most are from hospitals in the south or southeast of the
country (5). Camargo et al. recently typed by MLST 56 van-
comycin-sensitive and -resistant E. faecium strains from Brazil,
isolated from infected and colonized hospitalized patients, col-
onized volunteers in the community, and animals (4). Twenty-
six STs, which represented three groups of related strains and
19 singletons (eBURST analysis), were identified. Most van-
comycin-resistant E. faecium were ST 114, including those
from the first outbreak of VRE in Brazil (4). We have shown
here that strain 10/96A is not related to the VanA E. faecium
strains from Brazilian hospitals.
Indeed, we identified only two E. faecium strains in the
MLST database with STs closely related to ST 281, and al-
though the strains corresponding to ST 170 and ST 99 are
clinical isolates, neither is described as glycopeptide resistant.
Both of these closest relatives were double-locus variants of ST
281. Moreover, neither possessed the Ddl24 allele of strain
10/96A. This finding suggests that either (i) the ddl gene was
exchanged horizontally with more-distantly related strains,
such as those that exhibited greater sequence identity within
this locus (Fig. 1), (ii) or that, following acquisition of the
vancomycin-resistance gene cluster, under subsequent gly-
copeptide selection, spontaneous mutations in ddl were fa-
vored (because of the lack of a homolog to the vanX and
vanW D-D dipeptidase), leading independently to the out-
growth of the ddl mutation observed in the VanD strain
10/96A. Further studies are being directed toward determin
FIG. 1. Phylogenetic tree showing the relationships between 26 ddl alleles available at the E. faecium MLST database. The radial tree was
constructed by the neighbor-joining method with PhyloDraw, version 0.8, after clustering using ClustalW 1.8. The box highlights Ddl24 and the
most-related alleles.
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ing the rate and nature of mutation in ddl in VanD strains,
as well as the mechanism of acquisition or exchange of the
VanD gene cluster.
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FIG. 2. eBURST analysis of known E. faecium STs showing the ST 281 singleton and its two DLVs, ST 99 and ST 170.
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